Medicare to Negotiate Lower Prices for Weight-Loss Drugs
Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are likely to decline starting in 2027, thanks to their inclusion on a list of medicines whose prices will be negotiated directly between the government and drug makers. The Biden administration announced the list on Friday, but the incoming Trump administration will oversee the price…
